ArticleEuropean journal of nuclear medicine and molecular imaging2015

Preclinical evaluation and test-retest studies of [(18)F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5).

Selena Milicevic Sephton et al.PubMed ↗Publisher ↗

No numbers read from the abstract.